Advisory Committees
Roster of the Risk Communication Advisory Committee to the Food and Drug Administration
|
Applying for Membership on FDA Advisory Committees As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. Current Number of Vacancies 0 |
| Chair Baruch Fischhoff, Ph.D. Expertise: Risk Perception and Communication, Decision Analysis Term: 10/01/2007 – 09/30/2011 Howard Heinz University Professor Department of Social and Decision Sciences Department of Engineering and Public Policy Carnegie Mellon University Pittsburgh, PA 15213-3890 |
Executive Secretary Lee Zwanziger Office of Planning Office of the Commissioner Food and Drug Administration 5600 Fishers Lane, HFP-60 Rockville, MD 20857 rcac@fda.hhs.gov Tel 301-827-2895 Fax 301-827-5340 |
|
Craig Andrews, Ph.D. Christine M. Bruhn, Ph.D. Jacob DeLaRosa, M.D. AnnaMaria DeSalva Michael Goldstein, M.D. Sally Greenberg
|
Madeline Y. Lawson, M.A. Musa Mayer, M.S., M.F.A. Sokoya Finch Nealy, M.A. John E. Paling, Ph.D. Ellen M. Peters, Ph.D. Betsy Lynn Sleath, Ph.D. Michael S. Wolf, Ph.D., M.P.H.
|
| * As described in the charter for this committee, the membership includes no single designated consumer representative, but several voting members with experiential knowledge of risk communication including patient and consumer perspectives. Also as described in the charter, the membership includes no single designated industry representative, but depending on the meeting topic(s), at least one nonvoting member identified with relevant industry interests may be invited from existing members of other FDA Advisory Committees. |
Updated February 26, 2009

